Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal ...
Zacks.com on MSN9d
BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
DPA International on MSN9d
German vaccine manufacturer BioNTech to sponsor Bundesliga side Mainz
German vaccine manufacturer BioNTech is to sponsor Bundesliga side Mainz, the club announced on Friday. Mainz said the ...
Here's Why Everyone's Talking About Summit Therapeutics
Sales of Keytruda from Merck reached $25 billion last year thanks to its position as a standard first line of treatment for ...
Yahoo Finance9d
BioNTech SE (BNTX)
MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology ...
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's ...
FDA OKs third dose for Pfizer and Moderna Covid-19 vaccines
These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...
As a model in Covid-19 vaccination, Israel shows reduction in symptomatic and severe Covid-19 cases and possibly reduction in transmission
Overview of the Current Covid-19 Situation in Israel The Covid-19 vaccination program in Israel is progressing at a fast pace ...
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council
The (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, ...